ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Senior Manager, Commercial Reporting Strategy at Collegium Pharmaceutical - ApplyBlast

Senior Manager, Commercial Reporting Strategy

Collegium Pharmaceutical

2 months ago

3.1 on Glassdoor

Stoughton, Massachusetts, United States

Hybrid

Full Time

Senior

1 applicant

View Job Listing

Apply to 100+ jobs

About this role

The Senior Manager, Commercial Reporting Strategy leads the development and continuous improvement of Power BI dashboards and commercial reporting solutions, integrating AI and advanced analytics to provide actionable insights across sales, marketing, market access, trade, finance, and senior leadership. This role partners with business, data, IT, and vendor teams to ensure data quality, governance, and user adoption while managing external analytics vendors.

Responsibilities

Lead strategy and development of Power BI commercial reporting solutions
Identify and implement AI and advanced analytics use cases for business insights
Manage external vendors and governance for reporting and AI solutions

Skills

Qualifications

Bachelor's degree in Computer Science, Information Systems or related fieldMaster's degree in related field

About Collegium Pharmaceutical

collegiumpharma.com

Headquarters

Stoughton, Massachusetts, United States

Company Size

201-500 employees

View Profile

Collegium Pharmaceutical is a diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. The company builds a portfolio of differentiated medications spanning multiple therapeutic areas, including pain management and ADHD, with recent growth including the acquisition of AZSTARYS from Corium Therapeutics. Headquartered in Stoughton, Massachusetts, Collegium is publicly traded on NASDAQ (COLL) and combines development, regulatory, and commercial capabilities to bring meaningful medicines to patients across the U.S.